Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Interaction Map Rank Gene Network Comparison Type Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 644 to 693 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cpg binding protein (protein containing phd finger and cxxc domain 1). [source:swissprot;acc:q9p0u4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1144\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6837.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6281.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08858\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cpz gene product. [source:refseq;acc:nm\_003652]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
718\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7364.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6593.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.117\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
creatine kinase, b chain (ec 2.7.3.2) (b-ck). [source:swissprot;acc:p12277]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2735\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9019.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8991.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00313\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
creatine kinase, m chain (ec 2.7.3.2) (m-ck). [source:swissprot;acc:p06732]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2704\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9013.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8980.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0037\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
creatine kinase, sarcomeric mitochondrial precursor (ec 2.7.3.2) (s- mtck) (mib-ck) (basic-type mitochondrial creatine kinase). [source:swissprot;acc:p17540]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2702\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9006.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8971.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00393\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
creatine kinase, ubiquitous mitochondrial precursor (ec 2.7.3.2) (u- mtck) (mia-ck) (acidic-type mitochondrial creatine kinase). [source:swissprot;acc:p12532]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2703\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9007.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8972.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00388\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
crk-associated substrate (p130cas) (breast cancer anti-estrogen resistance 1 protein). [source:swissprot;acc:p56945]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
200\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6074.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4808.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26315\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
crk-like protein. [source:swissprot;acc:p46109]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
252\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
crooked neck-like protein 1 (crooked neck homolog) (hcrn) (cgi-201) (mstp021). [source:swissprot;acc:q9bzj0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
366\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6088.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5189\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17334\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ctcl tumor antigen l14-2. [source:refseq;acc:nm\_018017]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2846\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ctp synthase (ec 6.3.4.2) (utp--ammonia ligase) (ctp synthetase). [source:swissprot;acc:p17812]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
748\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11212\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12503.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11517\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cug triplet repeat rna-binding protein 1 (cug-bp1) (rna-binding protein brunol-2) (deadenylation factor cug-bp) (50 kda nuclear polyadenylated rna-binding protein) (eden-bp). [source:swissprot;acc:q92879]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2182\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6173.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5875.13\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05077\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
cug triplet repeat, rna binding protein 2; elav-type rna-binding protein; cug triplet repeat,rna-binding protein 2; cug triplet repeat, rna-binding protein 2; neuroblastoma apoptosis-related rna-binding protein. [source:refseq;acc:nm\_006561]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2183\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6173.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5875.11\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cullin homolog 1 (cul-1). [source:swissprot;acc:q13616]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
103\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3225.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
2353.63\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.3705\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
cullin homolog 2 (cul-2). [source:swissprot;acc:q13617]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
101\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-2 (activating transcription factor 2) (camp response element binding protein cre- bp1) (hb16). [source:swissprot;acc:p15336]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1480\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6085.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5660.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07509\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-3 (activating transcription factor 3). [source:swissprot;acc:p18847]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
78\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7132.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4800.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.48573\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-6 alpha (activating transcription factor 6 alpha) (atf6-alpha). [source:swissprot;acc:p18850]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1267\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6383.73\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5894.47\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.083\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-6 beta (activating transcription factor 6 beta) (atf6-beta) (camp responsive element binding protein-like 1) (camp response element binding protein-related protein) (creb-rp) (g13 protein). [source:swissprot;acc:q99941]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1264\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-7 (activating transcription factor 7) (transcription factor atf-a). [source:swissprot;acc:p17544]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1478\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6084.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5659.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07518\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cyclin c. [source:swissprot;acc:p24863]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1353\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6690.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6200.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07896\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cyclin g1 (cyclin g). [source:swissprot;acc:p51959]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
195\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
13995.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17738.5\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.26743\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
cyclin g2. [source:swissprot;acc:q16589]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
194\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
13995.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17738.6\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cyclin h (mo15-associated protein) (p37) (p34). [source:swissprot;acc:p51946]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2983\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
cyclin k. [source:swissprot;acc:o75909]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3160\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cyclin m1; ancient conserved domain protein 1. [source:refseq;acc:nm\_020348]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1222\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6226.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5735.74\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08551\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
cyclin m2; ancient conserved domain protein 2. [source:refseq;acc:nm\_017649]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1221\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6226.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5736.34\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
cyclin m3; ancient conserved domain protein 3. [source:refseq;acc:nm\_017623]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1220\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6226.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5735.65\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cyclin m4; ancient conserved domain protein 4. [source:refseq;acc:nm\_020184]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1218\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6226.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5736\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08552\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cyclin t1 (cyclin t) (cyct1). [source:swissprot;acc:o60563]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3002\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
cyclin t2. [source:swissprot;acc:o60583]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3171\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
cyclin-dependent kinase (cdc2-like) 11; death-preventing kinase. [source:refseq;acc:nm\_015076]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2892\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cyclin-dependent kinase 2-associated protein 1 (cdk2-associated protein 1) (putative oral cancer suppressor) (deleted in oral cancer- 1) (doc-1). [source:swissprot;acc:o14519]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
53\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1390.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
779.167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.78438\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cyclin-dependent kinases regulatory subunit 1 (cks-1) (sid1334) (pnas-16 / pnas-143). [source:swissprot;acc:p33551]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
301\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11466\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13768.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20078\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cyclin-dependent kinases regulatory subunit 2 (cks-2). [source:swissprot;acc:p33552]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
615\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9948.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11222.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12798\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cylindromatosis (turban tumor syndrome); cylindromatosis 1, turban tumor syndrome. [source:refseq;acc:nm\_015247]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1793\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6227.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5839.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06637\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cyr61 protein precursor (cysteine-rich, angiogenic inducer, 61) (insulin-like growth factor-binding protein 10) (gig1 protein). [source:swissprot;acc:o00622]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2938\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cystathionine beta-synthase (ec 4.2.1.22) (serine sulfhydrase) (beta-thionase). [source:swissprot;acc:p35520]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
560\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6222.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5480.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13536\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cystathionine gamma-lyase (ec 4.4.1.1) (gamma-cystathionase). [source:swissprot;acc:p32929]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
89\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1698.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2414.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.4217\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like 2 isoform a; autophagy-related cysteine endopeptidase 2; autophagin 2. [source:refseq;acc:nm\_052936]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
123\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
18172.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
24260.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.33503\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like isoform b. [source:refseq;acc:nm\_178326]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
126\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
18164.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
24250\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.33499\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cysteine-rich motor neuron 1; cysteine-rich repeat-containing protein s52 precursor. [source:refseq;acc:nm\_016441]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1303\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6852.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6334.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08185\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cysteine-rich protein 1 (crp1) (crp). [source:swissprot;acc:p21291]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2376\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3816.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3976.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04195\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cysteine-rich protein 1 (cysteine-rich intestinal protein) (crip) (cysteine-rich heart protein) (hcrhp). [source:swissprot;acc:p50238]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1024\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6245.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5706.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09446\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cysteine-rich secretory protein-1 precursor (crisp-1) (acidic epididymal glycoprotein homolog) (aeg-like protein) (arp). [source:swissprot;acc:p54107]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3018\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
cysteine-rich secretory protein-3 precursor (crisp-3) (sgp28 protein). [source:swissprot;acc:p54108]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3150\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cytidine deaminase (ec 3.5.4.5) (cytidine aminohydrolase). [source:swissprot;acc:p32320]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1547\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5790.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5397.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07286\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cytidine triphosphate synthase ii; ctp synthetase type 2; utp-ammonia ligase; ctp synthetase isoform; cytidine 5'-triphosphate synthetase 2. [source:refseq;acc:nm\_019857]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
744\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11221.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12515.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11535\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cytochrome b5 reductase 1 (b5r.1). [source:refseq;acc:nm\_016243]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
916\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6911.96\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6289.72\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09893\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
cytochrome b5 reductase b5r.2. [source:refseq;acc:nm\_016229]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
915\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/